Literature DB >> 16140514

Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.

Pavel Gershkovich1, Amnon Hoffman.   

Abstract

Association of a drug with chylomicrons in the enterocyte is an essential step in the lymphatic absorption pathway. In this article, the uptake of lipophilic compounds by chylomicrons ex vivo was compared to the corresponding intestinal lymphatic bioavailability reported in rats in order to elucidate the degree of correlation and to evaluate the utilization of this correlation as a predictive measurement of the lymphatic bioavailability potential of lipophilic drugs. Nine lipophilic compounds (Vitamin D(3), Vitamin E, halofantrine, probucol, diazepam, testosterone, cyclosporin A, benzo[a]pyrene and p,p'-DDT) at a concentration of 1.75 x 10(-6)M were incubated for 1h with chylomicron emulsion separated from rat blood. A strong linear correlation was found between the degree of association of compounds with chylomicrons ex vivo and the lymphatic transport reported in rats (r(2)=0.94, P<0.0001), whereas logP and solubility in long chain triglycerides showed only moderate correlation with lymphatic bioavailability. The linear correlation between the degree of uptake of compounds by isolated chylomicrons and intestinal lymphatic transport suggests that the two processes are governed by similar factors. Thus, the degree of association of lipophilic compounds with isolated chylomicrons can be used as a simple screening model for estimation of intestinal lymphatic transport potential of drug molecules. This approach is important in view of the practical difficulties in direct determination of the lymphatic bioavailability in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140514     DOI: 10.1016/j.ejps.2005.07.011

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  28 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.

Authors:  Manal A Elsheikh; Yosra S R Elnaggar; Dina Y Otify; Ossama Y Abdallah
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

3.  Probucol suppresses enterocytic accumulation of amyloid-β induced by saturated fat and cholesterol feeding.

Authors:  Menuka M Pallebage-Gamarallage; Susan Galloway; Ryusuke Takechi; Satvinder Dhaliwal; John C L Mamo
Journal:  Lipids       Date:  2011-07-31       Impact factor: 1.880

4.  A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport.

Authors:  Natalie L Trevaskis; Suzanne M Caliph; Gary Nguyen; Patrick Tso; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-02-21       Impact factor: 4.200

5.  The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport.

Authors:  Natalie L Trevaskis; Luojuan Hu; Suzanne M Caliph; Sifei Han; Christopher J H Porter
Journal:  J Vis Exp       Date:  2015-03-06       Impact factor: 1.355

6.  Intestinal Lymphatic Transport: an Overlooked Pathway for Understanding Absorption of Plant Secondary Compounds in Vertebrate Herbivores.

Authors:  Kevin D Kohl; M Denise Dearing
Journal:  J Chem Ecol       Date:  2017-03-02       Impact factor: 2.626

Review 7.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

8.  Bioavailability of seocalcitol IV: evaluation of lymphatic transport in conscious rats.

Authors:  Mette Grove; Jeanet L Nielsen; Gitte P Pedersen; Anette Müllertz
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

9.  Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines.

Authors:  Atheer Zgair; Jonathan Cm Wong; Jong Bong Lee; Jatin Mistry; Olena Sivak; Kishor M Wasan; Ivo M Hennig; David A Barrett; Cris S Constantinescu; Peter M Fischer; Pavel Gershkovich
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

10.  Vehicle-dependent disposition kinetics of fluoranthene in Fisher-344 rats.

Authors:  Deacqunita L Harris; Darry B Hood; Aramandla Ramesh
Journal:  Int J Environ Res Public Health       Date:  2008-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.